LENZ Therapeutics - 53 Year Dividend History | LENZ

Historical dividend payout and yield for LENZ Therapeutics (LENZ) since 1971. The current TTM dividend payout for LENZ Therapeutics (LENZ) as of July 18, 2024 is $0.00. The current dividend yield for LENZ Therapeutics as of July 18, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.080B $0.000B
Lenz Therapeutics Inc. is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision. Its product candidate includes LNZ100 and LNZ101, are preservative-free, single-use, once-daily, aceclidine-based eye drops currently in Phase 3 clinical trials for the treatment of presbyopia. Lenz Therapeutics Inc., formerly known as Graphite Bio Inc., is based in SOUTH SAN FRANCISCO, Calif.
Stock Name Country Market Cap PE Ratio